How much did Nuclein raise?

Nuclein raised $14 Million in a Private Equity round on March 26, 2021.

Where is Nuclein based and how big is it?

Nuclein is based in Austin, Texas, United States. Fundz records about 69 employees.

Who are the decision-makers at Nuclein?

Fundz holds 2 contacts at Nuclein, including the VP, Operations. Names and contact details are shown to Fundz members.

Nuclein Closes $14M In Funding Led By Trinity Private Equity Group

PRIVATEMar 26, 2021

Amount Raised

$14 Million

Round Type

Private Equity

AustinBiotechnology

Description

Medical device company aims to bring disposable, hand-held PCR test to market

Quick answer

Nuclein raised $14 Million in a Private Equity round, dated March 26, 2021. Nuclein is based in Austin, Texas, United States.

How much did Nuclein raise?: Nuclein raised $14 Million in a Private Equity round on March 26, 2021.
What does Nuclein do?: Nuclein, LLC is an Austin, Texas-based company founded in 2017 with a vision to enable simple, affordable, rapid, and accurate testing for everyone.
Where is Nuclein based and how big is it?: Nuclein is based in Austin, Texas, United States. Fundz records about 69 employees.
Who are the decision-makers at Nuclein?: Fundz holds 2 contacts at Nuclein, including the VP, Operations. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Nuclein that raised within 45 days of this round, from Fundz verified event records.

Triumvira Immunologics Inc. raised $16M on May 10, 2021.
CeleCor Therapeutics, Inc. raised $1M (Seed) on May 10, 2021.
Paragon Therapeutics, Inc. raised $10M on May 10, 2021.
Neochord raised $2.8M (Seed) on May 10, 2021.
Alebund Pharmaceutical raised $60M (Series B) on May 10, 2021.
Acworth Pharmaceuticals, Inc. raised $352K (Seed) on May 7, 2021.

Who to call at Nuclein, and when

A new round usually means Nuclein is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Nuclein raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Nuclein, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Nuclein. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Nuclein

Location

8305 Cross Park Dr

Austin, Texas, United States

About

Nuclein, LLC is an Austin, Texas-based company founded in 2017 with a vision to enable simple, affordable, rapid, and accurate testing for everyone. Its DASH® Rapid PCR System runs the FDA-cleared and CLIA-waived DASH® SARS-CoV-2 & Flu A/B Test and delivers lab-quality, point-of-care PCR results in 15 minutes. With a speed that is typically only available with antigen tests, the DASH® Rapid PCR System was designed to offer low-cost, sensitive and specific results, with robust multiplexing across various sample types, and requires less than one minute of hands-on time. Nuclein has raised approximately $50 million to date, led by private equity firm Trinity Investors. In 2023, Nuclein merged with Minute Molecular Diagnostics, Inc., a Northwestern University spin-out that initially developed the DASH System.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Nuclein raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

2 contacts

Verified contactsMark H., VP, Operations hidden hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Nuclein's next move

See what Strategic adds

Nuclein raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.